The Use of Alternative Medicine by Palliative Care Patients

• Sponsor: Hospices Civils de Lyon (Other)
• Overall Status: Completed
• CT.gov ID: NCT03260946
• Collaborator: (none)
• Enrollment: 120
• Locations: 3
• Actual Duration (Months): 9.7
• Patients Per Site: 40
• Patients Per Site Per Month: 4.1

Study Details

Study Description

Brief Summary

Palliative care centres in Lyon, France as well as the disclosure of Complementary and Alternative Medicine and conventional healthcare use to conventional and Complementary and Alternative Medicine practitioners respectively.

These aims will be achieved through the following objectives:

1. Describe the prevalence of Complementary and Alternative Medicine practitioner and product use in the outpatient population of palliative care centres in Lyon, France

2. Describe the characteristics of Complementary and Alternative Medicine users the outpatient population of palliative care centres in Lyon, France

3. Estimate the Complementary and Alternative Medicine expenditure of the outpatient population of palliative care centres in Lyon, France

4. Describe the rates of disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France

5. Describe the reasons for disclosure or non-disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France

Condition or Disease	Intervention/Treatment	Phase
Cancer; Terminal Cancer	Other: Complementary medicine use

Study Design

• Study Type: Observational
• Actual Enrollment: 120 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: The Use of Complementary Medicine in Palliative/Supportive Care Centres in Lyon, France
• Actual Study Start Date: Jul 11, 2017
• Actual Primary Completion Date: May 3, 2018
• Actual Study Completion Date: May 3, 2018

Arms and Interventions

Arm	Intervention/Treatment
Palliative/Supportive care Individuals with cancer receiving palliative or supportive care	Other: Complementary medicine use; The prevalence of complementary medicine use

Outcome Measures

Primary Outcome Measures

1. Complementary medicine use [15 minutes]

   The prevalence of complementary medicine use. Data collected using a questionnaire.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

1. Patients accessing care from a palliative/supportive care centre in Lyon, France

2. Can read and understand French

3. Has been diagnosed with cancer

Exclusion Criteria:

1. The primary health condition for which they are attending the centre is not cancer

2. They are not able to read and understand French

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	USP de Charmettes - Croix rouge française	Lyon		France	69006
2	Service E.M.S.P. Groupement Hospitalier Nord - Hôpital de la Croix-Rousse	Lyon		France	69317
3	Centre de Soins Palliatifs Lyon-Sud Pavillon 1K - Centre Hospitalier Lyon-Sud	Pierre-Bénite		France	69495

Sponsors and Collaborators

• Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Hospices Civils de Lyon
• ClinicalTrials.gov Identifier: NCT03260946
• Other Study ID Numbers: 69HCL17_0217
• First Posted: Aug 24, 2017
• Last Update Posted: Sep 24, 2018
• Last Verified: Aug 1, 2017

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Sep 24, 2018